Tripterygium regelii
Tripterygium regelii · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Tripterygium regelii is a medicinal plant that has garnered significant scientific interest due to its complex chemical profile. The bioactive compounds found within the plant include Iguesterin, celastrol, Pristimerin, and Tingenone. Researchers primarily focus on the root of the plant to extract these potent therapeutic agents. When processed into specific preparations, such as the bark, these substances demonstrate unique pharmacological properties. Current studies are particularly exploring the potential of these extracts in managing conditions like Multiple Myeloma.
- Synonyms
- Tripterygium Regelii F. Hypoleucum · Tripterygium Regelii Var. Occidentale · 2 more
- Common names
- Not available
- Family
- Celastraceae
- Distribution
- Asia-Temperate
- Plant Parts
- Root
Classification
Synonyms
Tripterygium regelii is a botanical species characterized by a complex web of taxonomic synonyms. Within scientific literature, it is frequently identified by various forms, such as Tripterygium regelii f. hypoleucum and Tripterygium regelii var. hypoleucum. The plant also encompasses the variety occidentale, which is listed as a synonym under its primary name. Additionally, the classification includes Tripterygium wilfordii var. regelii, reflecting its intricate relationship with related taxa. Understanding these shifting nomenclatural connections is essential for accurate botanical identification and research.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Tripterygium regelii is a fascinating botanical specimen belonging to the kingdom Plantae. This plant is classified under the class Equisetopsida, showcasing its unique evolutionary lineage. Within this group, it is specifically organized under the order Celastrales. It further belongs to the family Celastraceae, which helps scientists identify its closely related species. Finally, its precise identity is defined by its placement within the genus Tripterygium.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Celastrales |
| Family | Celastraceae |
| Genus | Tripterygium |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Tripterygium regelii is a plant species primarily found throughout the temperate regions of Asia. Its natural distribution spans across much of China, including the Manchuria region. The plant is also widely documented within the temperate landscapes of Eastern Asia, specifically in Japan. Furthermore, its presence extends into the various ecological zones of Korea. This broad geographic range highlights its significant footprint across the eastern territories of the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Tripterygium regelii exhibits a versatile structural nature, manifesting as a sturdy tree in certain environments. This plant is also characterized by its climbing liana growth habit, allowing it to sprawl across other vegetation.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Tripterygium regelii is a medicinal plant recognized for containing several bioactive compounds with significant pharmacological potential. Research indicates that it serves as a source for iguesterin, which has emerged as an excellent candidate for targeting the SARS-CoV 3CLpro protease. Additionally, the plant contains celastrol, a triterpene that can be utilized to study treatments for conditions such as multiple myeloma. Other important constituents isolated from this species include pristimerin and tingenone. Together, these diverse phytochemicals highlight the importance of exploring this plant for the development of new antiviral and anti-tumor therapies.
Conditions
Tripterygium regelii provides valuable therapeutic potential through its derivative, dihydrocelastrol, which treats multiple myeloma by inhibiting cell proliferation and promoting apoptosis. The plant also contains compounds like iguesterin that serve as excellent candidates for anti-SARS-CoV targeting 3CLpro. Furthermore, various isolated components from this species demonstrate potent inhibition of SARS-CoV-2 3CLpro activity. Beyond its antiviral capabilities, the genus Tripterygium is recognized as an immune suppressor in traditional Chinese medicine. These diverse biological activities highlight the complex medicinal profile of the plant in treating both hematological diseases and viral infections.
Preparations
Tripterygium regelii is prepared as bark to obtain specific medicinal components. From this bark, the compound iguesterin is isolated for therapeutic study. This substance has emerged as an excellent candidate for targeting the SARS-CoV 3CLpro protease. The systematic review highlights how the preparation of the plant's bark contributes to its potential anti-viral utility. Consequently, the use of the bark is a key aspect of extracting its bioactive properties.
Parts used
Tripterygium regelii serves as a significant source of bioactive chemical compounds in pharmacological research. Recent studies have focused on isolating specific abietane diterpenoids directly from the plant's root. One notable newly discovered compound, tripterregeline A, was identified alongside six other known diterpenoids through extensive spectroscopic analysis. These isolated substances were tested for their cytotoxic potential against several human cancer cell lines, including HL-60 and MCF-7. The findings revealed that these root-derived compounds exhibit significant inhibitory effects, marking them as promising candidates for further medicinal development.